Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    HomeNewsRanbaxylaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to
    • Check out: Super Six stocks for August 9

      Check out: Super Six stocks for August 9

      On CNBC-TV18's show Super Six, market gurus Manas Jaiswal, Technical Analyst, manasjaiswal.com, Rajesh Jain, EVP Retail Research, Religare Sec and Rakesh Gandhi, Sr Technical Analyst, LKP, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Bull's Eye: Short GMR Infra, Shree Renuka; buy Ranbaxy, PFC

      Bull's Eye: Short GMR Infra, Shree Renuka; buy Ranbaxy, PFC

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Short Kotak Mah Bank, buy Ranbaxy Labs: Panda

      Short Kotak Mah Bank, buy Ranbaxy Labs: Panda

      Jitendra Panda, HD - Sales Broking, Future Capital Ltd is of the view that short Kotak Mahindra Bank, buy Ranbaxy Laboratories.

    • Sell Apollo Tyres, buy Ranbaxy: Rakesh Bansal

      Sell Apollo Tyres, buy Ranbaxy: Rakesh Bansal

      Rakesh Bansal of rakeshbansal.com is of the view that one should buy Ranbaxy.

    • Sukhani's view on ITC, Ranbaxy

      Sukhani's view on ITC, Ranbaxy

      Sudarshan Sukhani of s2analytics.com is bullish in ITC and has recommended buy rating on the stock. Ranbaxy Laboratories has support at Rs 465.

    • Ranbaxy Laboratories has support at Rs 470-480: Mohindar

      Ranbaxy Laboratories has support at Rs 470-480: Mohindar

      Ranbaxy Laboratories is having support at around Rs 470-480, says Rahul Mohindar, Director, viratechindia.com.

    • Ranbaxy Labs can go upto Rs 520-530: Sukhani

      Ranbaxy Labs can go upto Rs 520-530: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that Ranbaxy Laboratories can go upto Rs 520-530.

    • Buy JK Tyre, Jet Airways, Ranbaxy: Abhishek Agarwal

      Buy JK Tyre, Jet Airways, Ranbaxy: Abhishek Agarwal

      In CNBC-TV18's popular show Bull's Eye, Abhishek Agarwal, Fortune Interfinance shares trading strategy of the day.

    • Bull's Eye: Buy Sesa Goa, MindTree, DLF; short GMR Infra

      Bull's Eye: Buy Sesa Goa, MindTree, DLF; short GMR Infra

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • 6 stocks likely to see lot of action today

      6 stocks likely to see lot of action today

      On CNBC-TV18's show Super Six, market gurus Vishal B Malkan of www.malkansview.com, Shardul Kulkarni of Angel Broking and Rajesh Jain of Religare Securities, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Ranbaxy Labs, ICICI Bank top picks: Amisha Vora

      Ranbaxy Labs, ICICI Bank top picks: Amisha Vora

      Ranbaxy Labs and ICICI Bank are the top picks, says Amisha Vora, Joint MD, Prabhudas Lilladher.

    • SP Tulsian positive on Ranbaxy Labs

      SP Tulsian positive on Ranbaxy Labs

      SP Tulsian, sptulsian.com is positive on Ranbaxy Labs with a target of Rs 510.

    • Short Ranbaxy, Divis Lab: Sukhani

      Short Ranbaxy, Divis Lab: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can short Ranbaxy and Divis Laboratories.

    • Ranbaxy, SBI, Power Grid look attractive: Bhat

      Ranbaxy, SBI, Power Grid look attractive: Bhat

      Ranbaxy, SBI and Power Grid are looking attractive at current levels, says Dilip Bhat, Joint MD, Prabhudas Lilladher.

    • Bull's Eye: Buy Wockhardt, McLeod Russel, BHEL

      Bull's Eye: Buy Wockhardt, McLeod Russel, BHEL

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Bull's Eye: Buy RCF, HDIL, BPCL, Tata Motors

      Bull's Eye: Buy RCF, HDIL, BPCL, Tata Motors

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Buy Divis Labs, Ranbaxy Labs, HUL on any dip: Chaturmohta

      Buy Divis Labs, Ranbaxy Labs, HUL on any dip: Chaturmohta

      Ashish Chaturmohta of IIFL Private Wealth Management is of the view that one buy Divis Laboratories, Ranbaxy Laboratories, Hindustan Unilever on any decline.

    • Buy Ranbaxy on every dip: Sukhani

      Buy Ranbaxy on every dip: Sukhani

      Buy Ranbaxy on every dip, says Sudarshan Sukhani of s2analytics.com.

    • Buy Ranbaxy Labs; avoid OMCs stocks: Sukhani

      Buy Ranbaxy Labs; avoid OMCs stocks: Sukhani

      Sudarshan Sukhani, s2analytics.com feels that one can buy Ranbaxy Laboratories and avoid OMCs stocks.

    • Super Six stocks you can bet on May 28

      Super Six stocks you can bet on May 28

      On CNBC-TV18's show Super Six, market gurus Vishal Malkan, CMT, www.malkansview.com, Manas Jaiswal of manasjaiswal.com and Nooresh Merani of AMSEC Research, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Super Six intraday picks for May 24

      Super Six intraday picks for May 24

      On CNBC-TV18's show Super Six, market gurus Vishal Kshatriya of Edelweiss Securities, Shardul Kulkarni, Angel Broking and Sanjeev Agarwal of Dynamix Research & Capital, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Ranbaxy Labs, Bajaj Auto good long term bets: Sukhani

      Ranbaxy Labs, Bajaj Auto good long term bets: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can bet on Ranbaxy Labs, Bajaj Auto and Apollo Tyres with two year time span.

    • Buy Ranbaxy Labs, says Sukhani

      Buy Ranbaxy Labs, says Sukhani

      Buy Ranbaxy Labs at current levels, says Sudarshan Sukhani, s2analytics.com.

    • Hold Ranbaxy Labs with a target of Rs 640: Agarwal

      Hold Ranbaxy Labs with a target of Rs 640: Agarwal

      Rajesh Agarwal of Eastern Financiers is of the view that one can hold Ranbaxy Laboratories with a one year target of Rs 640.

    • Buy Apollo Tyres, Cipla, Ranbaxy: Sukhani

      Buy Apollo Tyres, Cipla, Ranbaxy: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can bet on Apollo Tyres, Cipla, Ranbaxy.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347